SG194594A1 - Analyzing the expression of biomarkers in cells with clusters - Google Patents

Analyzing the expression of biomarkers in cells with clusters Download PDF

Info

Publication number
SG194594A1
SG194594A1 SG2013078753A SG2013078753A SG194594A1 SG 194594 A1 SG194594 A1 SG 194594A1 SG 2013078753 A SG2013078753 A SG 2013078753A SG 2013078753 A SG2013078753 A SG 2013078753A SG 194594 A1 SG194594 A1 SG 194594A1
Authority
SG
Singapore
Prior art keywords
cell
clusters
cells
cluster
sets
Prior art date
Application number
SG2013078753A
Other languages
English (en)
Inventor
Colin Craig Mcculloch
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of SG194594A1 publication Critical patent/SG194594A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00Pattern recognition
    • G06F18/20Analysing
    • G06F18/21Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/211Selection of the most significant subset of features
    • G06F18/2115Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06VIMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00Arrangements for image or video recognition or understanding
    • G06V10/70Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/771Feature selection, e.g. selecting representative features from a multi-dimensional feature space
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06VIMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00Scenes; Scene-specific elements
    • G06V20/60Type of objects
    • G06V20/69Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/698Matching; Classification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Data Mining & Analysis (AREA)
  • Artificial Intelligence (AREA)
  • Multimedia (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Software Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Computing Systems (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
SG2013078753A 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters SG194594A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161478224P 2011-04-22 2011-04-22
US13/252,069 US20120270752A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,080 US20120271553A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,078 US20120269419A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,072 US20120269418A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
PCT/EP2012/057395 WO2012143562A2 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters

Publications (1)

Publication Number Publication Date
SG194594A1 true SG194594A1 (en) 2013-12-30

Family

ID=47021377

Family Applications (4)

Application Number Title Priority Date Filing Date
SG2013078753A SG194594A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters
SG2013078688A SG194588A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters
SG2013078712A SG194590A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with moments
SG2013078738A SG194592A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with moments

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG2013078688A SG194588A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters
SG2013078712A SG194590A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with moments
SG2013078738A SG194592A1 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with moments

Country Status (8)

Country Link
US (5) US20120270752A1 (cg-RX-API-DMAC7.html)
EP (4) EP2700042B1 (cg-RX-API-DMAC7.html)
JP (4) JP6063447B2 (cg-RX-API-DMAC7.html)
BR (4) BR112013027123A2 (cg-RX-API-DMAC7.html)
CA (4) CA2833428A1 (cg-RX-API-DMAC7.html)
RU (3) RU2013145154A (cg-RX-API-DMAC7.html)
SG (4) SG194594A1 (cg-RX-API-DMAC7.html)
WO (4) WO2012143558A2 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111594D0 (en) * 2011-07-06 2011-08-24 Equateq Ltd New improved process
KR20150094618A (ko) * 2012-12-06 2015-08-19 클래리언트 다이아그노스틱 서비시즈, 인크. 생물학적 시편의 분할 스크린 디스플레이와 그 레코드를 포착하기 위한 시스템 및 방법
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
US8995740B2 (en) * 2013-04-17 2015-03-31 General Electric Company System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue
EP3017302B1 (en) * 2013-07-03 2019-04-24 Coyne Scientific, LLC Methods for predicting responses to chemical or biologic substances
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
US9298968B1 (en) * 2014-09-12 2016-03-29 Flagship Biosciences, Inc. Digital image analysis of inflammatory cells and mediators of inflammation
US10167514B2 (en) 2015-01-22 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for determining proportions of distinct cell subsets
US9953133B2 (en) 2015-06-03 2018-04-24 General Electric Company Biological data annotation and visualization
US10672505B2 (en) 2015-06-03 2020-06-02 General Electric Company Biological data annotation and visualization
US10796130B2 (en) * 2015-12-22 2020-10-06 Nikon Corporation Image processing apparatus
US20180032681A1 (en) * 2016-07-29 2018-02-01 General Electric Company Biological feature analysis technique
WO2018151223A1 (ja) * 2017-02-16 2018-08-23 国立大学法人京都大学 細胞評価方法、細胞評価装置、及び細胞評価プログラム
US10242473B2 (en) * 2017-03-22 2019-03-26 Sas Institute Inc. Computer system to generate scalable plots using clustering
EP3616213A2 (en) * 2017-04-28 2020-03-04 4D Path Inc. Apparatus, systems, and methods for rapid cancer detection
KR101990430B1 (ko) * 2017-06-22 2019-06-18 한국과학기술원 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법
EP4546353A3 (en) 2017-07-21 2025-07-23 The Board of Trustees of the Leland Stanford Junior University Systems and methods for analyzing mixed cell populations
US10706328B2 (en) * 2018-05-07 2020-07-07 Google Llc Focus-weighted, machine learning disease classifier error prediction for microscope slide images
US10971255B2 (en) * 2018-09-14 2021-04-06 Zasti Inc. Multimodal learning framework for analysis of clinical trials
WO2020068684A2 (en) 2018-09-24 2020-04-02 Krishnan Ramanathan Hybrid analysis framework for prediction of outcomes in clinical trials
WO2020112478A1 (en) * 2018-11-29 2020-06-04 Somalogic, Inc. Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
US11128667B2 (en) * 2018-11-29 2021-09-21 Rapid7, Inc. Cluster detection and elimination in security environments
CN113158982A (zh) * 2021-05-17 2021-07-23 广东中卡云计算有限公司 一种半介入式的目标关键点标注方法
WO2023033056A1 (ja) * 2021-09-01 2023-03-09 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
IT202200001817A1 (it) 2022-02-02 2023-08-02 Aizoon S R L Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico
IT202200005861A1 (it) 2022-03-24 2023-09-24 Aizoon S R L Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico
US20240028964A1 (en) 2022-07-25 2024-01-25 Aizoon S.r.l. Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5740269A (en) * 1994-09-20 1998-04-14 Neopath, Inc. Method and apparatus for robust biological specimen classification
US6996549B2 (en) * 1998-05-01 2006-02-07 Health Discovery Corporation Computer-aided image analysis
US6282305B1 (en) * 1998-06-05 2001-08-28 Arch Development Corporation Method and system for the computerized assessment of breast cancer risk
US6337472B1 (en) * 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
WO2002059377A2 (en) * 2001-01-24 2002-08-01 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
US20060210129A1 (en) * 2002-07-30 2006-09-21 Deutsches Krebsforschungzentrum Method and apparatus for multiple labeling detection and evaluation of a plurality of particles
US20040121413A1 (en) * 2002-12-20 2004-06-24 Aebersold Rudolf H. Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
US20050265588A1 (en) * 2004-02-03 2005-12-01 Bioimagene, Inc. Method and system for digital image based flourescent in situ hybridization (FISH) analysis
EP1872124A4 (en) * 2005-04-19 2008-06-11 Prediction Sciences Llc DIAGNOSTIC MARKERS FOR THE TREATMENT AND EVOLUTION OF BREAST CANCER AND METHODS OF USE
US8041090B2 (en) * 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
US7933435B2 (en) * 2005-11-21 2011-04-26 Vala Sciences, Inc. System, method, and kit for processing a magnified image of biological material to identify components of a biological object
CN101484806A (zh) * 2006-05-17 2009-07-15 协乐民公司 一种对组织进行自动分析的方法
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
EP2132327A2 (en) * 2007-03-27 2009-12-16 Rosetta Genomics Ltd Gene expression signature for classification of cancers
AU2008247379A1 (en) * 2007-05-07 2008-11-13 Ge Healthcare Bio-Sciences Corp. System and method for the automated analysis of cellular assays and tissues
ATE528722T1 (de) * 2007-05-14 2011-10-15 Historx Inc Abteilungsauftrennung durch pixelcharakterisierung unter verwendung von bilddatenclusterung
ES2618353T3 (es) * 2007-09-06 2017-06-21 Biotheranostics, Inc. Clasificación de tumores y pronóstico del cáncer de mama
US9779213B2 (en) * 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US9858389B2 (en) * 2008-07-25 2018-01-02 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Method and system for determining the risk of occurrence of prostate cancer
US8320655B2 (en) * 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
WO2011087778A1 (en) * 2009-12-22 2011-07-21 The Children's Hospital Of Philadelphia Automated quantitative multidimensional volumetric analysis and visualization

Also Published As

Publication number Publication date
RU2013145162A (ru) 2015-05-27
JP6143743B2 (ja) 2017-06-07
EP2700037A2 (en) 2014-02-26
CA2833804A1 (en) 2012-10-26
WO2012143556A2 (en) 2012-10-26
JP2014517954A (ja) 2014-07-24
BR112013027122A2 (pt) 2017-01-10
EP2700042B1 (en) 2021-03-17
SG194588A1 (en) 2013-12-30
WO2012143562A3 (en) 2013-02-28
WO2012143558A2 (en) 2012-10-26
EP2700038A2 (en) 2014-02-26
JP6063447B2 (ja) 2017-01-18
EP2700036A2 (en) 2014-02-26
EP2700038B1 (en) 2021-04-21
BR112013027124A2 (pt) 2017-01-10
WO2012143562A2 (en) 2012-10-26
WO2012143556A3 (en) 2013-05-30
EP2700042A2 (en) 2014-02-26
JP2014516413A (ja) 2014-07-10
CA2833497A1 (en) 2012-10-26
RU2013145154A (ru) 2015-05-27
SG194592A1 (en) 2013-12-30
JP2014521925A (ja) 2014-08-28
CA2833295A1 (en) 2012-10-26
WO2012143561A3 (en) 2013-05-23
WO2012143558A3 (en) 2012-12-20
US20120270752A1 (en) 2012-10-25
CA2833428A1 (en) 2012-10-26
JP6063446B2 (ja) 2017-01-18
BR112013027123A2 (pt) 2017-01-10
SG194590A1 (en) 2013-12-30
RU2013145151A (ru) 2015-05-27
JP6163152B2 (ja) 2017-07-12
BR112013027125A2 (pt) 2017-01-10
US20120271553A1 (en) 2012-10-25
JP2014521926A (ja) 2014-08-28
US20120269419A1 (en) 2012-10-25
US20120269418A1 (en) 2012-10-25
US20140185905A1 (en) 2014-07-03
WO2012143561A2 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
EP2700038B1 (en) Analyzing the expression of biomarkers in cells with moments
US8885912B2 (en) Generate percentage of positive cells for biomarkers by normalizing and autothresholding the image intensity produced by immunohistochemistry technique
US11636288B2 (en) Platform, device and process for annotation and classification of tissue specimens using convolutional neural network
US11315774B2 (en) Big-data analyzing Method and mass spectrometric system using the same method
EP2751730A2 (en) Systems and methods for tissue classification
WO2021161901A1 (ja) 特徴量選択方法、特徴量選択プログラム、マルチクラス分類方法、マルチクラス分類プログラム、特徴量選択装置、マルチクラス分類装置、及び特徴量セット
WO2022065216A1 (ja) 特徴量選択方法、特徴量選択プログラム、及び特徴量選択装置、マルチクラス分類方法、マルチクラス分類プログラム、及びマルチクラス分類装置、並びに特徴量セット
Zhang et al. Predicting IHC staining classes of NF1 using features in the hematoxylin channel
WO2011119967A2 (en) System,method and computer-accessible medium for evaluating a maliganacy status in at-risk populations and during patient treatment management
Yach Proximity Effects in Multiplexed Immunohistochemistry Images of Breast Cancer
Khan et al. Impact of prostate biopsy tumor amount on imaging based prognostics employing transductive semi-supervised regression
Hashmi et al. Malignant Genes Growth Utilizing ScRNA Sequencing Information by AI Applications
Hradel et al. Interpretable diagnosis of breast cancer from histological images using Siamese neural networks
Li Novel Population Specific Computational Pathology-based Prognostic and Predictive Biomarkers for Breast Cancer
Zubek et al. Aggregating Multiple Biological Measurements Per Patient